Literature DB >> 24058176

Defining CD8+ T cell determinants during human viral infection in populations of Asian ethnicity.

Laura Rivino1, Anthony T Tan, Adeline Chia, Emmanuelle A P Kumaran, Gijsbert M Grotenbreg, Paul A MacAry, Antonio Bertoletti.   

Abstract

The identification of virus-specific CD8(+) T cell determinants is a fundamental requirement for our understanding of viral disease pathogenesis. T cell epitope mapping strategies increasingly rely on algorithms that predict the binding of peptides to MHC molecules. There is, however, little information on the reliability of predictive algorithms in the context of human populations, in particular, for those expressing HLA class I molecules for which there are limited experimental data available. In this study, we evaluate the ability of NetMHCpan to predict antiviral CD8(+) T cell epitopes that we identified with a traditional approach in patients of Asian ethnicity infected with Dengue virus, hepatitis B virus, or severe acute respiratory syndrome coronavirus. We experimentally demonstrate that the predictive power of algorithms defining peptide-MHC interaction directly correlates with the amount of training data on which the predictive algorithm has been constructed. These results highlight the limited applicability of the NetMHCpan algorithm for populations expressing HLA molecules for which there are little or no experimental binding data, such as those of Asian ethnicity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24058176     DOI: 10.4049/jimmunol.1301507

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: implication for the development of an universal CD8+ T-cell epitope-based vaccine.

Authors:  Sarah Samandary; Hédia Kridane-Miledi; Jacqueline S Sandoval; Zareen Choudhury; Francina Langa-Vives; Doran Spencer; Aziz A Chentoufi; François A Lemonnier; Lbachir BenMohamed
Journal:  Hum Immunol       Date:  2014-05-04       Impact factor: 2.850

Review 2.  Transcriptomic immune profiles of human flavivirus-specific T-cell responses.

Authors:  Alba Grifoni; Yuan Tian; Alessandro Sette; Daniela Weiskopf
Journal:  Immunology       Date:  2020-01-07       Impact factor: 7.397

Review 3.  CD4+ and CD8+ T-cell immunity to Dengue - lessons for the study of Zika virus.

Authors:  Laura Rivino; Mei Qiu Lim
Journal:  Immunology       Date:  2016-11-27       Impact factor: 7.397

Review 4.  Host genetic control of mosquito-borne Flavivirus infections.

Authors:  Caroline Manet; Claude Roth; Ahmed Tawfik; Tineke Cantaert; Anavaj Sakuntabhai; Xavier Montagutelli
Journal:  Mamm Genome       Date:  2018-08-25       Impact factor: 2.957

Review 5.  Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells.

Authors:  Evan W Newell; Mark M Davis
Journal:  Nat Biotechnol       Date:  2014-01-19       Impact factor: 54.908

6.  Human T cell responses to Dengue and Zika virus infection compared to Dengue/Zika coinfection.

Authors:  Jessica Badolato-Corrêa; Juan Camilo Sánchez-Arcila; Thiara Manuele Alves de Souza; Luciana Santos Barbosa; Priscila Conrado Guerra Nunes; Monique da Rocha Queiroz Lima; Mariana Gandini; Ana Maria Bispo de Filippis; Rivaldo Venâncio da Cunha; Elzinandes Leal de Azeredo; Luzia Maria de-Oliveira-Pinto
Journal:  Immun Inflamm Dis       Date:  2017-12-28

Review 7.  Development of Peptide Vaccines in Dengue.

Authors:  Kavita Reginald; Yanqi Chan; Magdalena Plebanski; Chit Laa Poh
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

Review 8.  Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges.

Authors:  Idris Nasir Abdullahi; Anthony Uchenna Emeribe; Hafeez Aderinsayo Adekola; Sharafudeen Dahiru Abubakar; Amos Dangana; Halima Ali Shuwa; Sunday Theophilus Nwoba; Jelili Olaide Mustapha; Muyideen Titilope Haruna; Kafayat Adepeju Olowookere; Olawale Sunday Animasaun; Charles Egede Ugwu; Solomon Oloche Onoja; Abdullahi Sani Gadama; Musa Mohammed; Isa Muhammad Daneji; Dele Ohinoyi Amadu; Peter Elisha Ghamba; Nkechi Blessing Onukegbe; Muhammad Sagir Shehu; Chiladi Isomah; Adamu Babayo; Abdurrahman El-Fulaty Ahmad
Journal:  Hum Vaccin Immunother       Date:  2020-09-16       Impact factor: 3.452

9.  Landscape and selection of vaccine epitopes in SARS-CoV-2.

Authors:  Christof C Smith; Kelly S Olsen; Benjamin G Vincent; Alex Rubinsteyn; Kaylee M Gentry; Maria Sambade; Wolfgang Beck; Jason Garness; Sarah Entwistle; Caryn Willis; Steven Vensko; Allison Woods; Misha Fini; Brandon Carpenter; Eric Routh; Julia Kodysh; Timothy O'Donnell; Carsten Haber; Kirsten Heiss; Volker Stadler; Erik Garrison; Adam M Sandor; Jenny P Y Ting; Jared Weiss; Krzysztof Krajewski; Oliver C Grant; Robert J Woods; Mark Heise
Journal:  Genome Med       Date:  2021-06-14       Impact factor: 15.266

Review 10.  Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development.

Authors:  Claude Roth; Félix G Delgado; Etienne Simon-Lorière; Anavaj Sakuntabhai
Journal:  Int J Environ Res Public Health       Date:  2018-02-23       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.